First-Line Jaktinib for Acute Graft-Versus-Host Disease (aGVHD)
Clinical trial NCT07285889 · RECRUITING
Trial details
- NCT number
- NCT07285889
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-03
- Primary completion
- 2027-12-31
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.